Reading SXT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SXT free→Reading SXT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SXT free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, but earnings quality is fragile, reported profits aren't backed by cash. Risk is moderate, and the sector backdrop is a headwind, which may impact future growth. Peer multiples imply a price about 61% below where it trades (it looks expensive on this basis); the read is expensive, growth-justified, as it is rich on today's multiple, but the three-year horizon reads cheaper once expected earnings growth is included. Key factors to watch include guidance changes and sector trends, particularly how bellwethers perform. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $124.11. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $124 the market pays 34× p/e — above the 20× p/e peer median but in line with its own 28× history. That premium reflects a durable franchise our peer-anchored $77 fair value understates; treat the 'expensive vs peers' read with medium confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 61% near-term growth, well above our forecast of about 4%. This describes what's priced in, not a forecast of the move.
Flags: expensive valuation, weak execution quality. Capped at elevated by the Crisis regime.
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Materials names rated strong grew net income 63% of the time over the next year (vs 54% for the rest of the cohort, n=1093).
Over the trailing year it converted 0.85x of net income into operating cash flow. Historically, Materials names rated fragile grew net income 46% of the time over the next year (vs 57% for the rest of the cohort, n=988).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.99 → $1.04 (+4.7% / 30d). 2 raised, 0 cut, 3 covering analysts.
0 upgrades, 0 downgrades / 30d. 75% of analysts rate Buy.
Market and fundamentals agree. Analysts are positioned bullishly on a fundamentally strong name.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$114.
How much price usually moves either way.
On a bad day, this stock has moved -$282.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $3,070.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Better sector performance could support Sensient's stock as it faces headwinds.
Confirms:Sector performance is getting better. It shows a positive trend for the next 30 days.
Disproves:Sector performance continues to decline over the next 30 days.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for SXT yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. Sensient Technologies Corporation (the “Company”) issued a press release on April 24, 2026, disclosing its results of operations for its quarter ended March 31, 2026, and its financial condition at that date. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Item 2.02 (including Exhibit 99.1) is intended to be furnished under
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Specialty Chemicals.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
SXT Sensient Technologies | Above typical Show detailsSector percentile: 87 of 100 | expensive | moderate |
SHW Sherwin-Williams | Above typical Show detailsSector percentile: 71 of 100 | full | moderate |
ECL Ecolab | Above typical Show detailsSector percentile: 85 of 100 | expensive | moderate |
PPG PPG Industries | Above typical Show detailsSector percentile: 90 of 100 | fair | moderate |
LYB LyondellBasell | Typical Show detailsSector percentile: 54 of 100 | — | moderate |
Not investment advice. As of 2026-06-12.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Sensient aims for high single-digit to double-digit growth in local currency revenue.
Sensient has increased its EPS guidance for the fiscal year 2026.
Sensient targets high single-digit to double-digit growth in local currency adjusted EBITDA.
Why it matters: If the sector's revenue growth turns positive, it may signal a recovery. This could benefit Sensient's performance.
Confirms:Sector revenue growth is positive after being negative for three years.
Disproves:Sector revenue growth remains negative.
Why it matters: Improving revenue growth would signal a positive shift in demand for Sensient's products.
Confirms:Q2 revenue growth exceeds 1% compared to Q1.
Disproves:Q2 revenue growth remains below 1% compared to Q1.